MitoRX’s new obesity drug targets metabolism, not appetite

A mitochondrial therapy that leaves hunger untouched could signal a new chapter in obesity treatment and perhaps in healthy aging. “Eat less.” That’s how obesity medicine has been defined. The rise of GLP-1 drugs transformed the field by helping people feel fuller, consume fewer calories and lose unprecedented amounts of weight. The results have been […] The post MitoRX’s new obesity drug targets metabolism, not appetite appeared first on Longevity.Technology .

This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.